Definitive radiotherapy and Single-Agent radiosensitizing Ifosfamide in Patients with localized, irresectable Soft Tissue Sarcoma: A retrospective analysis

Radiation Oncology

Volumn 5, Issue 1, 2010, Pages

  Eckert, Franziska ^a   Matuschek, Christiane ^b   Mueller, Arndt Christian ^a   Weinmann, Martin ^a   Hartmann, Joerg T ^c   Belka, Claus ^d   Budach, Wilfried ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IFOSFAMIDE; ALKYLATING AGENT; RADIOSENSITIZING AGENT;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; FEMALE; HIGH RISK BEHAVIOR; HUMAN; HYPERTHERMIA; MALE; OVERALL SURVIVAL; PROGNOSIS; RADIATION DOSE; RADIOSENSITIZATION; RETROSPECTIVE STUDY; SOFT TISSUE SARCOMA; TREATMENT FAILURE; CANCER STAGING; CASE REPORT; FOLLOW UP; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; SARCOMA; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; ANTINEOPLASTIC AGENTS, ALKYLATING; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; IFOSFAMIDE; MALE; MIDDLE AGED; NEOPLASM STAGING; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SARCOMA; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 77953532913     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-5-55     Document Type: Article

References (22)

1. Swallow CJ, Catton CN. Local management of adult soft tissue sarcomas. Semin Oncol 2007, 34:256-269. 10.1053/j.seminoncol.2007.03.008, 17560988.
2. Hartmann JT. Systemic treatment options for patients with refractory adult-type sarcoma beyond anthracyclines. Anticancer Drugs 2007, 18:245-254. 10.1097/CAD.0b013e3280124e41, 17264755.
3. Kaushal A, Citrin D. The role of radiation therapy in the management of sarcomas. Surg Clin North Am 2008, 88:629-646. viii, 10.1016/j.suc.2008.03.005, 2517216, 18514703.
4. Thornton K. Chemotherapeutic management of soft tissue sarcoma. Surg Clin North Am 2008, 88:647-660. viii, 10.1016/j.suc.2008.03.004, 18514704.
5. Raut CP, Pisters PW. Retroperitoneal sarcomas: Combined-modality treatment approaches. J Surg Oncol 2006, 94:81-87. 10.1002/jso.20543, 16788949.
6. Kepka L, DeLaney TF, Suit HD, Goldberg SI. Results of radiation therapy for unresected soft-tissue sarcomas. Int J Radiat Oncol Biol Phys 2005, 63:852-859.
7. Goffman T, Tochner Z, Glatstein E. Primary treatment of large and massive adult sarcomas with iododeoxyuridine and aggressive hyperfractionated irradiation. Cancer 1991, 67:572-576. 10.1002/1097-0142(19910201)67:3<572::AID-CNCR2820670308>3.0.CO;2-D, 1985751.
8. Maki RG. Role of chemotherapy in patients with soft tissue sarcomas. Expert Rev Anticancer Ther 2004, 4:229-236. 10.1586/14737140.4.2.229, 15056053.
9. Anderson P, Aguilera D, Pearson M, Woo S. Outpatient chemotherapy plus radiotherapy in sarcomas: improving cancer control with radiosensitizing agents. Cancer Control 2008, 15:38-46.
10. Grier HE, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003, 348:694-701. 10.1056/NEJMoa020890, 12594313.
11. Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS, Evans HL. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 225 patients. Cancer 2003, 97:2530-2543. 10.1002/cncr.11365, 12733153.
12. Kinsella TJ, Glatstein E. Clinical experience with intravenous radiosensitizers in unresectable sarcomas. Cancer 1987, 59:908-915. 10.1002/1097-0142(19870301)59:5<908::AID-CNCR2820590509>3.0.CO;2-Z, 3815269.
13. Rhomberg W, Hassenstein EO, Gefeller D. Radiotherapy vs. radiotherapy and razoxane in the treatment of soft tissue sarcomas: final results of a randomized study. Int J Radiat Oncol Biol Phys 1996, 36:1077-1084.
14. Toma S, Palumbo R, Sogno G, Canavese G, Barra S, Marziano C, Serrano J, Albanese E, Rosso R. Concomitant radiation-doxorubicin administration in locally advanced and/or metastatic soft tissue sarcomas: preliminary results. Anticancer Res 1991, 11:2085-2089.
15. Budach W, Reinelt A, Paulsen F, Belka C, Stueben G. Radiation therapy in combination with ifosfamide (IFO) in Human Soft Tissue Sarcoma (STS) Xenografts. Radiother Oncol 1998, 48(Suppl 1).
16. Brodowicz T, Schwameis E, Widder J, Amann G, Wiltschke C, Dominkus M, Windhager R, Ritschl P, Potter R, Kotz R, Zielinski CC. Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial. Sarcoma 2000, 4:151-160. 2395444, 18521295.
17. Sauer R, Schuchardt U, Hohenberger W, Wittekind C, Papadopoulos T, Grabenbauer GG, Fietkau R. Neoadjuvant radiochemotherapy in soft tissue sarcomas. Optimization of local functional tumor control. Strahlenther Onkol 1999, 175:259-266. 10.1007/BF02743576, 10392166.
18. Le QT, Fu KK, Kroll S, Fitts L, Massullo V, Ferrell L, Kaplan MJ, Phillips TL. Prognostic factors in adult soft-tissue sarcomas of the head and neck. Int J Radiat Oncol Biol Phys 1997, 37:975-984.
19. Willers H, Hug EB, Spiro IJ, Efird JT, Rosenberg AE, Wang CC. Adult soft tissue sarcomas of the head and neck treated by radiation and surgery or radiation alone: patterns of failure and prognostic factors. Int J Radiat Oncol Biol Phys 1995, 33:585-593.
20. Kepka L, Suit HD, Goldberg SI, Rosenberg AE, Gebhardt MC, Hornicek FJ, Delaney TF. Results of radiation therapy performed after unplanned surgery (without re-excision) for soft tissue sarcomas. J Surg Oncol 2005, 92:39-45. 10.1002/jso.20351, 16180232.
21. Cheifetz R, Catton CN, Kandel R, O'Sullivan B, Couture J, Swallow CJ. Recent progress in the management of retroperitoneal sarcoma. Sarcoma 2001, 5:17-26. 10.1080/13577140120048908, 2395448, 18521304.
22. Pervaiz N, Colterjohn N, Farrokhyar F, Tozer R, Figueredo A, Ghert M. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer 2008, 113:573-581. 10.1002/cncr.23592, 18521899.